BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22378485)

  • 21. PTCA with the use of cardiac assist devices: risk stratification, short- and long-term results.
    Ferrari M; Scholz KH; Figulla HR
    Cathet Cardiovasc Diagn; 1996 Jul; 38(3):242-8. PubMed ID: 8804779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative percutaneous coronary intervention in patients undergoing open thoracoabdominal and descending thoracic aneurysm repair.
    Girardi LN; Rabotnikov Y; Avgerinos DV
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):163-8. PubMed ID: 24176270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.
    Kovacic JC; Nguyen HT; Karajgikar R; Sharma SK; Kini AS
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):E28-37. PubMed ID: 21234916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery.
    Capodanno D; Giacoppo D; Dipasqua F; Miccichè E; Licitra C; Di Salvo ME; Francaviglia B; Grasso C; La Manna A; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E446-52. PubMed ID: 23592634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging.
    Kirschbaum SW; Springeling T; Boersma E; Moelker A; van der Giessen WJ; Serruys PW; de Feyter PJ; van Geuns RJ
    JACC Cardiovasc Interv; 2010 Apr; 3(4):392-400. PubMed ID: 20398866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A first-in-man study of the Reitan catheter pump for circulatory support in patients undergoing high-risk percutaneous coronary intervention.
    Smith EJ; Reitan O; Keeble T; Dixon K; Rothman MT
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):859-65. PubMed ID: 19455649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.
    Thomas JL; Al-Ameri H; Economides C; Shareghi S; Abad DG; Mayeda G; Burstein S; Shavelle DM
    J Invasive Cardiol; 2010 Aug; 22(8):360-4. PubMed ID: 20679671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the predictive value of EuroSCORE, SYNTAX score, and clinical SYNTAX score for outcomes of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease.
    Jou YL; Lu TM; Chen YH; Sung SH; Wang KL; Huang SS; Lin WT; Chan WL; Lin SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):222-30. PubMed ID: 22334399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.
    Brener SJ; Lytle BW; Casserly IP; Schneider JP; Topol EJ; Lauer MS
    Circulation; 2004 May; 109(19):2290-5. PubMed ID: 15117846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what?
    Shah R; Thomson A; Atianzar K; Somma K; Mehra A; Clavijo L; Matthews RV; Shavelle DM
    Cardiovasc Revasc Med; 2012; 13(2):101-5. PubMed ID: 22406055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivessel percutaneous coronary intervention: a new paradigm for a new century.
    Morrison DA
    Minerva Cardioangiol; 2005 Oct; 53(5):361-77. PubMed ID: 16179881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.
    Marui A; Kimura T; Nishiwaki N; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Eur J Cardiothorac Surg; 2015 Feb; 47(2):316-21; discussion 321. PubMed ID: 24662243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.
    Yates MT; Soppa GK; Valencia O; Jones S; Firoozi S; Jahangiri M
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):606-10. PubMed ID: 23402690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease.
    Buszman PP; Bochenek A; Konkolewska M; Trela B; Kiesz RS; Wilczyński M; Cisowski M; Krejca M; Banasiewicz-Szkróbka I; Krol M; Kondys M; Wiernek S; Orlik B; Martin JL; Tendera M; Buszman PE
    J Invasive Cardiol; 2009 Nov; 21(11):564-9. PubMed ID: 19901409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome.
    Lehmann R; Spyridopoulos I; Kremer J; Zeiher AM; Schächinger V; Fichtlscherer S
    J Interv Cardiol; 2009 Aug; 22(4):311-9. PubMed ID: 19689656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Koch KT; van der Schaaf RJ; Vis MM; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):532-7. PubMed ID: 17896398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction.
    Nardi P; Pellegrino A; Scafuri A; Colella D; Bassano C; Polisca P; Chiariello L
    Ann Thorac Surg; 2009 May; 87(5):1401-7. PubMed ID: 19379873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Kar B; Forrester M; Gemmato C; Civitello A; Loyalka P; Myers T; Reynolds D
    J Invasive Cardiol; 2006 Mar; 18(3):93-6. PubMed ID: 16598104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.